Every Form 4 that Accuray Incorporated (ARAY) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ARAY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ARAY filings page.
Accuray Inc. (ARAY) SVP Chief Financial Officer Pervaiz Ali acquired 19,811 shares of common stock on September 23, 2026, in connection with achieving performance-related measures. On the same date, the issuer withheld 8,915 shares to satisfy tax withholding and remittance obligations tied to net settlement of RSUs. A footnote says the post-transaction amount includes 2,500 shares acquired May 29, 2026 under the Accuray Employee Stock Purchase Plan, in transactions exempt under Rule 16b-3(c).
ACCURAY INC (ARAY) reported that TCW Group, Inc., a ten percent owner, indirectly acquired new warrants to purchase a total of 8,585,857 shares of Accuray common stock on July 29, 2026. These consist of warrants for 7,987,743 shares and 598,114 shares, each with a $0.01 exercise price and expiring July 29, 2033.
The warrants were issued by Accuray to TCW-affiliated holders under a Securities Purchase Agreement and a Limited Waiver and Amendment to a Financing Agreement. The filing states that, after this issuance, TCW holds warrants to purchase 27,527,916 Accuray common shares and disclaims beneficial ownership beyond its pecuniary interest. No Rule 10b5-1 trading plan is reported.
Miele Paul Michael reported acquisition or exercise transactions in this Form 4 filing.
ACCURAY INC granted Senior Vice President and Chief Commercial Officer Paul Michael Miele 650,000 restricted stock units (RSUs), each representing a contingent right to receive one share of common stock. This is an equity-based compensation award rather than an open-market stock purchase or sale.
According to the vesting schedule, one-fourth of the RSUs is scheduled to vest on April 30, 2027, with additional one-fourth portions vesting on each of the first, second, and third anniversaries of that date. After this grant, Miele is shown as holding 650,000 RSUs directly, aligning his compensation more closely with the company’s future share performance over several years.
ACCURAY INC reported that an affiliated business unit of The TCW Group, Inc. received several warrants to purchase common stock as part of a financing arrangement. On May 19, 2026, entities within the TCW business unit, including TCW Rescue Financing Fund II LP and West Virginia Direct Lending LLC, were issued multiple warrant tranches with exercise prices ranging from $0.01 to $1.50 per share, all expiring on May 19, 2033.
The warrants were issued as consideration for making a Delayed Draw Term Loan under a Financing Agreement and no separate cash consideration was paid for the warrants. After this issuance, TCW reports warrants to purchase 18,942,059 shares of Accuray common stock, while disclaiming beneficial ownership beyond its pecuniary interest.
Accuray Inc SVP tax-withholding share disposition
Accuray Inc executive Sandeep Chalke, the SVP and Chief Commercial Officer, reported a tax-related share disposition. On this Form 4, 40,000 shares of Common Stock were withheld by the company at an implied price of $0.3881 per share to cover tax obligations tied to RSU vesting.
These shares were not sold in the open market but used to satisfy tax withholding and remittance requirements in a net settlement of restricted stock units. After this transaction, Chalke directly holds 419,806 shares of Accuray Inc common stock.
Accuray SVP and COO Leonel Peralta reported equity compensation transactions involving restricted stock units and common stock. On February 28, 2026, he exercised 83,723 restricted stock units, receiving the same number of common shares at $0.00 per share. To satisfy tax withholding obligations related to this net settlement, 28,969 common shares were withheld by the company at $0.55 per share, as described in the footnote. After these transactions, Peralta directly owned 54,754 shares of Accuray common stock.
Accuray Inc. director Steven F. Mayer purchased 54,875 shares of Accuray common stock in an open-market transaction on February 20, 2026. The shares were bought at a weighted-average price of $0.5627 per share, with individual trade prices ranging from $0.5334 to $0.5897. Following this purchase, Mayer directly owns 1,545,620 shares of Accuray common stock.
Accuray Inc. director Steven F. Mayer reported open-market purchases of the company’s common stock. He bought 126,125 shares on February 18, 2026 at a weighted average price of $0.5328 per share and 69,000 shares on February 19, 2026 at a weighted average price of $0.5304 per share. These transactions increased his direct holdings to 1,490,745 shares of Accuray common stock.
Accuray director Byron C. Scott reported equity award activity tied to his retirement from the Board of Directors on December 31, 2025. On that date, 9,433 restricted stock units were converted into an equal number of common shares at an exercise price of $0, with vesting accelerated due to his retirement. Also on December 31, 2025, 3,774 common shares were withheld at $0.8246 per share to cover a cash settlement election under the grant agreement, reducing the reported common stock position to 158,953 shares held directly. Following these transactions, he also held 47,170 restricted stock units directly, including an award that vests 100% on November 13, 2026.
Accuray Inc. (ARAY) director Joseph Whitters reported an equity award transaction. On 11/21/2025, 56,603 restricted stock units (RSUs) were converted into shares of Accuray common stock at an exercise price of $0, coded as an "M" transaction (option or derivative conversion).
After this conversion, Whitters beneficially owns 667,656 shares of Accuray common stock in direct ownership. Each RSU represents a contingent right to receive one share of common stock, and this RSU grant was structured to vest 100% on 11/21/2025, triggering the share issuance reported here.
Accuray Inc. (ARAY) director reports equity transactions in a Form 4. On 11/21/2025, the director settled 56,603 restricted stock units (RSUs), receiving the same number of shares of Accuray common stock at an exercise price of $0. On the same date, 22,642 shares of common stock were disposed of at $1.05 per share, described as shares forfeited due to a cash settlement election made in the grant agreement. After these transactions, the director beneficially owned 153,294 shares of Accuray common stock, held directly.
Accuray Inc. director transaction: A director of Accuray Inc. (ARAY) reported the vesting and settlement of 56,603 restricted stock units (RSUs) into shares of common stock on 11/21/2025. The RSUs converted at an exercise price of $0, meaning the director did not pay cash to receive the shares. Each RSU represented the right to receive one share of Accuray common stock and this RSU grant vested 100% on that date. Following this transaction, the director beneficially owned 212,659 shares of Accuray common stock in direct ownership.
Accuray Inc. director reports RSU vesting and share acquisition
A director of Accuray Inc. (ARAY) reported the vesting and settlement of restricted stock units into common stock. On 11/21/2025, 45,620 restricted stock units converted into 45,620 shares of Accuray common stock at an exercise price of $0, reported with transaction code "M," which indicates a derivative-to-equity conversion. Following this transaction, the director beneficially owns 400,229 shares of Accuray common stock in direct form. The reported restricted stock units were a grant that was scheduled to vest 100% on 11/21/2025, with each unit representing the right to receive one share of common stock.
Accuray Inc. director reports RSU vesting and share acquisition
A director of Accuray Inc. (ARAY), Anne Bryce Le Grand, reported the vesting of restricted stock units and related share acquisition. On 11/21/2025, 56,603 restricted stock units were converted to the same number of shares of Accuray common stock at an exercise price of $0, reported under transaction code "M." Each RSU represented a contingent right to receive one share of common stock and this RSU award vested 100% on that date.
Following this transaction, the reporting person beneficially owns 259,499 shares of Accuray common stock in direct form and no longer holds any of the reported derivative RSUs. This filing is a routine disclosure of insider equity compensation activity and ownership under the securities rules.
Accuray Inc. (ARAY) director Beverly A. Huss reported equity transactions involving company stock. On 11/21/2025, a grant of 56,603 restricted stock units (RSUs) was settled into an equivalent number of common shares at an exercise price of $0 per share. On the same date, 22,642 shares were forfeited, as noted, due to a cash settlement election made by the director in the grant agreement at a reported price of $1.05 per share. Following these transactions, the director directly beneficially owned 221,323 shares of Accuray common stock.
Each RSU represents a contingent right to receive one share of Accuray common stock, and the referenced RSU grant was scheduled to vest 100% on 11/21/2025.
Accuray Inc. (ARAY) director reports RSU vesting and share acquisition. A company director filed a Form 4 disclosing the conversion of 56,603 restricted stock units (RSUs) into an equal number of shares of Accuray common stock on 11/21/2025 through a transaction coded “M” (option or derivative exercise). The RSUs had an exercise price of $0, meaning the director did not pay cash to receive the shares. After this transaction, the director beneficially owns 294,804 shares of Accuray common stock in direct ownership. Each RSU represented a contingent right to receive one share, and this RSU grant vested 100% on 11/21/2025.
Accuray Inc. (ARAY) CEO and director Stephen R. La Neve reported an open-market purchase of 20,000 shares of common stock on 11/19/2025. The transaction was reported at a weighted average purchase price of $0.9705 per share, with individual trades executed between $0.9699 and $0.9708. Following this purchase, La Neve beneficially owns 20,000 shares directly. The filing notes that detailed trade-by-trade pricing information within the stated range is available upon request.
Accuray Inc. director Robert Kill reported the conversion of 56,603 restricted stock units into common stock on 11/13/2025 at an exercise price of $0 per share. Following this transaction, he beneficially owned 162,809 shares of Accuray common stock directly. The RSUs were originally scheduled to vest 100% on 11/21/2025, but the vesting and settlement into shares were accelerated to 11/13/2025 in connection with his retirement from the Board of Directors.
Accuray (ARAY) reported a Form 4 for CEO and director Stephen R. La Neve showing equity awards granted on 10/31/2025. The filing discloses 1,250,000 Restricted Stock Units (RSUs) and 1,250,000 Performance Stock Units (PSUs), each unit representing the right to receive one share of common stock.
The RSUs vest in four equal tranches, with 25% on each of the first, second, third, and fourth anniversaries of the grant date. The PSUs vest upon Accuray’s common stock achieving a specified price per share during designated performance periods. Following the reported transactions, 1,250,000 RSUs and 1,250,000 PSUs are shown as beneficially owned, held directly.
Accuray (ARAY) reported an officer transaction tied to RSU settlement on 10/31/2025. The filer acquired 37,500 shares of Common Stock at $0 via transaction code M and had 12,001 shares withheld at $1.41 under code F to cover taxes. Following these entries, the officer beneficially owned 25,499 shares directly. Derivative holdings reflected 112,500 Restricted Stock Units after the transaction, with RSUs vesting 25% annually over four years from grant.
Accuray Incorporated (ARAY) disclosed a director equity grant. On 10/31/2025, a director acquired 354,609 shares of common stock classified as restricted shares under the Accuray Incorporated Amended and Restated 2016 Equity Incentive Plan.
The shares were recorded at a transaction price of $0 and are held directly. Following the transaction, the director beneficially owned 354,609 common shares. The award vests 100% on the first anniversary of the grant date.